ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 293 filers reported holding ICU MED INC in Q4 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $513,807 | +10.8% | 4,327 | +0.1% | 0.00% | 0.0% |
| Q1 2024 | $463,929 | +28.1% | 4,323 | +19.1% | 0.00% | 0.0% |
| Q4 2023 | $362,042 | -44.4% | 3,630 | -33.7% | 0.00% | -50.0% |
| Q3 2023 | $651,681 | +79.8% | 5,476 | +169.2% | 0.00% | +100.0% |
| Q2 2023 | $362,412 | +28640.0% | 2,034 | -73.4% | 0.00% | -75.0% |
| Q1 2023 | $1,261 | -52.5% | 7,643 | -54.7% | 0.00% | -55.6% |
| Q4 2022 | $2,657 | -99.9% | 16,874 | +4.6% | 0.01% | -10.0% |
| Q3 2022 | $2,429,000 | -1.3% | 16,129 | +7.7% | 0.01% | 0.0% |
| Q2 2022 | $2,462,000 | -35.5% | 14,980 | -8.4% | 0.01% | -50.0% |
| Q3 2021 | $3,819,000 | +38.1% | 16,362 | +21.8% | 0.02% | +17.6% |
| Q2 2021 | $2,765,000 | +572.7% | 13,437 | +723.9% | 0.02% | +240.0% |
| Q2 2019 | $411,000 | +13.9% | 1,631 | +8.2% | 0.01% | 0.0% |
| Q1 2019 | $361,000 | +44.4% | 1,508 | +70.6% | 0.01% | -16.7% |
| Q3 2018 | $250,000 | -2.7% | 884 | +1.1% | 0.01% | -14.3% |
| Q2 2018 | $257,000 | – | 874 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
| CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
| PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
| Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
| GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
| Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
| Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
| PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
| DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
| GAM Holding AG | 90,452 | $20,769,000 | 1.05% |